RANBP2 and viral infectious disease: We observed that the efficiency of HSV-1-GFP infection was comparable between Ctrl and RanBP2-dE3-3 Vero cells (Figure S4B–D), confirming that RanBP2 might only affect viral infection by interfering with antiviral innate immunity.